European Medicines Agency  [to 16 December 2017]
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 December 2017
Seven medicines recommended for approval, including an advanced therapy …

European Vaccine Initiative  [to 16 December 2017]
14 December 2017
ZIKAVAX Annual Meeting 2017
The first annual meeting of the EU-funded project ZIKAVAX took place on 7 December 2017 at CEA,…
FDA [to 16 December 2017]
December 15, 2017 –
Statement from FDA Commissioner Scott Gottlieb, M.D., on new FDA efforts to support more efficient development of targeted therapies
New website streamlines how FDA updates information used to help health care providers choose an appropriate treatment for a patient’s infection
Fondation Merieux  [to 16 December 2017]
December 12, 2017
REAOLAB presents the overview of phase 2 durig its 5th Steering Committee meeting held in Mali
The RESAOLAB project brought together the partners and networks members in Bamako for its 5th International Committee Meeting on 5 and 6 December 2017. This meeting was an opportunity to take stock of the achievements of phase 2 while reporting on the continuation of the program. A workshop dedicated to antimicrobial resistance, an increasing public health challenge, and a round table on the future of young researchers in West Africa, were also organized on this occasion.
GHIT Fund   [to 16 December 2017]
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that devastate the world’s poorest people. Other funders include six Japanese pharmaceutical ·
Press Room   2017.12.11      
GHIT Fund’s Strategic Plan for 2018 to 2022: Accelerating Product Development and Product Delivery for its global health innovations

TOKYO, JAPAN (December 11, 2017)—The Global Health Innovative Technology Fund (GHIT) today announced its Strategic Plan targeting the next five years (FY2018-FY2022). Comprised of four pillars—i: Research & Development (R&D), ii: Partnership for Delivery, iii: Excellence through Good Governance, iv: Financial Strategies—GHIT will continue to accelerate global health R&D through an international partnership between Japan and countries overseas.
Since its inception in April 2013 as the world’s first global health R&D public-private partnership fund, GHIT has advanced the development of therapeutics, vaccines and diagnostics for infectious disease in low and middle income countries, by galvanizing Japan’s science and pharmaceutical capabilities. To date, GHIT has invested a total of US$115M in 68 global partnerships, and 7 clinical trials are currently underway…

Global Fund [to 16 December 2017];&country=
Kenya and Global Fund Sign New Grants to Accelerate Response to Diseases
15 December 2017
The Global Fund and health partners in Kenya today signed six grant agreements to strengthen the response to HIV, tuberculosis and malaria. The grants aim to reach 1.3 million people with antiretroviral therapy by 2021, and drastically expand interventions to find more missing cases of TB, among other objectives.
Hilleman Laboratories   [to 16 December 2017]
12th October 2017
Hilleman Labs successfully completes Phase I/II Clinical Trial of its Heat Stable Rotavirus Vaccine (HSRV)
New Delhi: Making headway towards providing the developing nations an affordable and easy-to-use Heat Stable Rotavirus Vaccine (HSRV), Hilleman Laboratories, a joint-venture between Merck Sharp & Dohme (MSD) and the Wellcome Trust, today announced the successful completion of Phase I/II clinical trial of its oral vaccine against the deadly Rotavirus disease.
The study was conducted in partnership with the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)…
Human Vaccines Project   [to 16 December 2017]
Public Release: 13-Dec-2017
New Michelson Prizes for Human Immunology and Vaccine Research launch
The Michelson Medical Research Foundation and the Human Vaccines Project announce young investigator prizes to advance the development of future vaccines and therapies to defeat major global diseases
[See Milestones/Perspectives above for more detail]

IVAC  [to 16 December 2017]
Statement on Dengvaxia® issued by Global Dengue & Aedes-Transmitted Diseases Consortium (GDAC) with support from International Vaccine Access Center
JEE Alliance  [to 16 December 2017]
Strong health systems are essential for resilience and preparedness – time for synergy and joining up
Health security contributes to peace and security, democracy, economic and social stability as well as wellbeing. Strengthening health security is therefore an integral target of the SDGs…
MSF/Médecins Sans Frontières  [to 16 December 2017]
Press release
MSF: At Least 6,700 Rohingya Killed During Attacks in Myanmar
December 14, 2017
NEW YORK/AMSTERDAM/PARIS—At least 9,000 members of the ethnic Rohingya minority died—most of them from violence— in Rakhine state, Myanmar, between August 25 and September 24, according to surveys conducted in refugee settlement camps in Bangladesh and released today by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF).

Press release
Yemen: Diphtheria Spreads as War and Blockade Leave Health System in Tatters
December 12, 2017
Doctors Without Borders/Médecins Sans Frontières (MSF) is responding to a suspected outbreak of diphtheria in Yemen, where the disease has reemerged as the country’s health system is weakened by ongoing war and a blockade on essential goods.
PATH  [to 16 December 2017]
Press release | December 12, 2017
Launch of ‘Be Me. Be Happy!’: A campaign to increase transgender women’s access to HIV services in Vietnam

UNAIDS [to 16 December 2017]
15 December 2017 –
UNAIDS PCB discusses discrimination in health-care settings

14 December 2017 –
Closing the HIV resource gap in Nigeria with more domestic funding

13 December 2017 –
Key populations platform in Ukraine established

12 December 2017
41st meeting of the UNAIDS Programme Coordinating Board opens

UNICEF  [to 16 December 2017]
15 December 2017
World Bank and WHO: Half the world lacks access to essential health services, 100 million still pushed into extreme poverty because of health expenses
TOKYO, December 13, 2017 — At least half of the world’s population cannot obtain essential health services, according to a new report from the World Bank and the World Health Organization. And each year, large numbers of households are being pushed into poverty because they must pay for health care out of their own pockets.
[See Milestones/Perspectives above for more detail]

Three months after deadly hurricanes hit Caribbean islands, thousands of children still in need of assistance
PANAMA CITY, 13 December 2017 – Three months after two category-5 hurricanes – Irma and Maria – barreled through the Caribbean, causing widespread damage and loss of life, thousands of children remain in need of support across the region.

New funding will allow countries to secure sustainable vaccine supplies and reach children more quickly
COPENHAGEN, 13 December 2017 – UNICEF announced today that funding for its Vaccine Independence Initiative (VII), a mechanism to help countries secure a sustainable supply of life-saving vaccines, has more than doubled in the past year, increasing from $15 million to $35 million.
[See Milestones/Perspectives above for more detail]

Bangladesh moves to protect Rohingya children from diphtheria
COX’S BAZAR, Bangladesh, 12 December 2017 – The Government of Bangladesh, with the support of UNICEF, the World Health Organization and GAVI, the Vaccine Alliance, today launched  a vaccination campaign against diphtheria and other preventable diseases for all Rohingya children aged 6 weeks to 6 years living in 12 camps and temporary settlements near the Myanmar border.
[See Emergencies above for more detail]

Wellcome Trust  [to 16 December 2017]
News / Published: 12 December 2017
Wellcome’s charitable spend reaches record levels
Wellcome spent over £1.1 billion on science, research, innovation and public engagement in 2016-17, more than ever before and double what we spent a decade ago.
Explainer / Published: 11 December 2017
Sharing Clinical Trial Data: what it means for you
Wellcome is joining (CSDR), a data-sharing initiative involving academic research funders and pharmaceutical companies. Jen O’Callaghan, from our Open Research team, explains why and what it means for researchers.
As a global research foundation, we’re dedicated to ensuring that the outputs of the research we fund – including clinical trial data – can be accessed and used in ways that will advance medical science by building on previous findings and exploring new questions.
CSDR (opens in a new tab) is a website portal for listing and sharing clinical trial datasets. Initially established to provide a way in which researchers could access trial data from a consortium of 13 pharmaceutical companies, CSDR is now expanding to include data from academic-led trials….

IFPMA   [to 16 December 2017]
13 December 2017
10th annual G-FINDER report: Pharmaceutical industry R&D investment funding for negected diseases
Geneva, 13 December 2017: IFPMA, the international association representing the research-based biopharmaceutical companies, welcomes the 10th annual G-FINDER report[i] results that show industry contributed USD 497m to global R&D efforts, accounting for 16% of total global funding. The report notes that industry funding has reached new record highs for the last three years. Since 2008, reported industry investment has increased by nearly 50%. This firmly consolidates industry’s position as the 3rd largest funder of R&D for neglected diseases after the US NIH and the Bill and Melinda Gates Foundation…